LINCOLNSHIRE Ill. May 16 2014 /PRNewswire/ -- TOLMAR Pharmaceuticals Inc. focused on specialty pharmaceutical products today announced that effective May 8 2014 the company holds exclusive distribution rights to ELIGARD® (leuprolide acetate for injectable suspension) in the U.S. and Puerto Rico.ELIGARD is a prescription medication for the palliative treatment (management of symptoms) of ...
News Source
News Source
No comments:
Post a Comment